Events
Register and find information for upcoming events from BioSpace and partners.
Interested in publishing your upcoming event on BioSpace? Submit events here.
Interested in putting on your own event? Talk to us.
Upcoming Events
Disease is driven by complex biological networks that remain only partially understood until experimentally resolved as a whole. Targets and compounds advance without clear biological understanding, leading to failure. AI and large-scale experimental data have scaled hypotheses and insights. The bottleneck now shifts to biological resolution.
Wednesday, May 13, 2026 11am–12pm EDT
·
Virtual
Navigating AI, Globalization, and Integration while Demonstrating Strategic Value
Monday, April 20, 2026 7:30–11:30am EDT
·
Barcelona, Spain
In this webinar, an AsymBio expert will discuss robust analytical strategies for tackling challenges in analytical method development for CQA measurement, including DAR determination, drug load distribution, free drug, and charge variant analysis.
Wednesday, April 22, 2026 10–11am EDT
·
Virtual
A premier, industry-driven forum uniting pharma, biotech, and academic leaders to advance drug discovery.
Monday, April 27, 2026 9am–5pm PDT
·
Palo Alto, CA
Work with the BioSpace Insights team to engage decision-makers through thoughtful and impactful content.
Past Events
Watch this critical discussion on how regulators and biotech companies can bridge the expectation gap during the regulatory review process to ensure novel therapies reach patients in a timely manner—because patients don’t have time to wait.
More Past Events
With venture funding tightening in the post-COVID landscape, efficiency has become more critical than ever. In this interactive webinar industry experts explored actionable strategies for maintaining quality under financial pressure. Watch now.
Are long R&D cycles, overwhelming literature reviews, or patent bottlenecks slowing your path to innovation? In the fast-evolving life science landscape, AI is no longer a luxury, it’s a necessity.
BioSpace’s NextGen companies are rising in one of the most confounding biotech markets ever experienced. Executives sounded off on how to keep your head above water during our webinar, Are We There Yet?
BioSpace sits down with four NextGen companies that are thriving despite a multi-year down period. You will hear about ways they are defying the odds to churn out clinical data that may finally provide the industry with a ladder out. Watch now.
In this discussion, our guests explore how recent regulatory changes are shaping the future of AI in drug development in the US market. Watch now.